NCT00880464View on ClinicalTrials.gov

Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 1, 2006

Primary Completion Date

October 31, 2011

Study Completion Date

June 30, 2021

Conditions
Breast Cancer
Interventions
BIOLOGICAL

Autologous, Lethally Irradiated Breast Cancer Cells

Vaccination with autologous tumor cells engineered by adenoviral mediated gene transfer to secrete GM-CS

Trial Locations (2)

02115

Brigham and Women's Hospital, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00880464 - Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer | Biotech Hunter | Biotech Hunter